| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.46▼ | 7.48▼ | 7.51▼ | 7.48▼ | 7.60▼ |
| MA10 | 7.46▼ | 7.54▼ | 7.50▼ | 7.57▼ | 7.81▼ |
| MA20 | 7.47▼ | 7.50▼ | 7.44▲ | 7.68▼ | 8.05▼ |
| MA50 | 7.55▼ | 7.47▼ | 7.49▼ | 7.90▼ | 7.39▲ |
| MA100 | 7.49▼ | 7.51▼ | 7.65▼ | 8.10▼ | 6.39▲ |
| MA200 | 7.44▲ | 7.69▼ | 7.64▼ | 7.58▼ | 6.63▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.011▼ | 0.011▲ | -0.024▼ | -0.139▼ |
| RSI | 38.542▼ | 45.948▼ | 47.853▼ | 45.617▼ | 46.915▼ |
| STOCH | 44.167 | 22.012 | 63.399 | 28.698 | 21.615 |
| WILL %R | -66.667 | -65.217 | -45.918 | -73.284 | -83.516▼ |
| CCI | -118.443▼ | -88.969 | -5.851 | -62.284 | -99.482 |
|
Thursday, February 05, 2026 03:59 PM
MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and ...
|
|
Tuesday, February 03, 2026 05:45 AM
The agreement grants MeiraGTx exclusive rights to ZipBio’s first-in-class therapies targeting the complement pathway for Geographic Atrophy, a progressive eye disease with significant unmet medical ...
|
|
Tuesday, February 03, 2026 05:25 AM
ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 7.48 | 7.695 | 7.26 | 7.45 | 240,814 |
| 12/02/26 | 7.50 | 7.64 | 7.162 | 7.36 | 352,641 |
| 11/02/26 | 7.53 | 7.63 | 7.30 | 7.46 | 296,774 |
| 10/02/26 | 7.61 | 7.63 | 7.49 | 7.52 | 251,232 |
| 09/02/26 | 7.42 | 7.70 | 7.22 | 7.63 | 320,672 |
| 06/02/26 | 7.34 | 7.57 | 7.215 | 7.43 | 613,805 |
| 05/02/26 | 7.66 | 7.85 | 7.17 | 7.20 | 473,335 |
| 04/02/26 | 8.04 | 8.06 | 7.60 | 7.78 | 286,645 |
| 03/02/26 | 7.90 | 8.24 | 7.87 | 8.04 | 406,775 |
| 02/02/26 | 7.63 | 8.0231 | 7.5079 | 7.83 | 490,505 |
|
|
||||
|
|
||||
|
|